首頁
Genomic Health Inc

11月 2025Genomic Health Inc的市場佔有率分析

Genomic Health was a company focusing on genetic research specifically in cancer detection, based out of Redwood City, California. The company was acquired by and merged with Exact Sciences Corporation in 2019.

健康 > 生物技術和製藥

域名genomichealth.com

成立年份2000

僱員501 - 1000

年度營收$200M - $500M

Genomic Health Inc

Genomic Health Inc（包含公司地區）

genomichealth.com

查看更多網站流量與參與度資訊

Genomic Health Inc截至 11月 2025 的總收入為 200M - 500M

Genomic Health Inc 熱門網域產生的總收入

Genomic Health Inc 熱門網域 3 年內的總收入

Genomic Health Inc 熱門網域的總收入

genomichealth.com200M - 500M

透過銷售情報查看更多內容

Genomic Health Inc的熱門網域總造訪量

了解Genomic Health Inc市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

genomichealth.com825

透過銷售情報查看更多內容

Genomic Health Inc的熱門網域平均造訪時長

分析Genomic Health Inc參與度指標。

過去 3 個月平均造訪時長

子公司細目

genomichealth.com00:00:36

透過銷售情報查看更多內容

Genomic Health Inc的熱門網域平均頁面瀏覽量

了解Genomic Health Inc如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

genomichealth.com3.01

透過銷售情報查看更多內容

Genomic Health Inc按網域劃分的熱門競爭對手

11月 2025的熱門類似網站，依相似度排名

foundationmedicine.com公司名Foundation Medicine僱員1001 - 5000總部美國, 馬薩諸塞州, Cambridge年度營收$200M - $500M訪問總量41.2K健康 > 生物技術和製藥

使用的熱門技術Genomic Health Inc

这些是Genomic Health Inc顶级域名使用的行业网站技术

付款與貨幣 (25)

PayPal

付費廣告 (10)

DoubleClick

轉換與分析 (7)

Google Analytics

社群 (5)

Instagram

更多技術

11

檢視所有

新聞與訊號來自Genomic Health Inc

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞MDxHealth partnered with Genomichealth on Aug 2nd '22.MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company”), a commercial-stage precision diagnostics company, today announced it has entered into an asset purchase agreement with Genomic Health, Inc., a subsidiary of Exact Sciences Corporation (“Exact Sciences”), to acquire the Oncotype DX® GPS (Genomic Prostate Score®) test from Exact Sciences along with most of its team of urology sales and marketing professionals.

新聞Genomichealth launched Oncotype DX AR-V7 nucleus detect test on Feb 1st '18.March 2018 – Oncotype DX AR-V7 nucleus detect test, a predictive and prognostics biomarker was launched by Genomic Health Inc.

新聞Genomichealth hired F. Murray as System Chief of the Division of Genomic Medicine and Clinical Director of the Institute on Sep 26th '23.Michael F. Murray, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, has been named the new System Chief of the Division of Genomic Medicine and the Clinical Director of the Institute for Genomic Health at Mount Sinai.